Free Trial

Cognition Therapeutics (CGTX) Competitors

Cognition Therapeutics logo
$0.34 +0.02 (+7.33%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$0.35 +0.02 (+4.71%)
As of 04:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CGTX vs. ZURA, ONCY, QNCX, PYXS, BMEA, INCR, ABOS, IMUX, IKNA, and MNOV

Should you be buying Cognition Therapeutics stock or one of its competitors? The main competitors of Cognition Therapeutics include Zura Bio (ZURA), Oncolytics Biotech (ONCY), Quince Therapeutics (QNCX), Pyxis Oncology (PYXS), Biomea Fusion (BMEA), InterCure (INCR), Acumen Pharmaceuticals (ABOS), Immunic (IMUX), Ikena Oncology (IKNA), and MediciNova (MNOV). These companies are all part of the "pharmaceutical products" industry.

Cognition Therapeutics vs. Its Competitors

Cognition Therapeutics (NASDAQ:CGTX) and Zura Bio (NASDAQ:ZURA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

Cognition Therapeutics currently has a consensus price target of $2.83, indicating a potential upside of 745.27%. Zura Bio has a consensus price target of $14.33, indicating a potential upside of 1,179.76%. Given Zura Bio's stronger consensus rating and higher probable upside, analysts plainly believe Zura Bio is more favorable than Cognition Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cognition Therapeutics
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00
Zura Bio
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13

Zura Bio is trading at a lower price-to-earnings ratio than Cognition Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cognition TherapeuticsN/AN/A-$33.97M-$0.74-0.45
Zura BioN/AN/A-$45.39M-$0.70-1.60

43.4% of Cognition Therapeutics shares are owned by institutional investors. Comparatively, 61.1% of Zura Bio shares are owned by institutional investors. 14.4% of Cognition Therapeutics shares are owned by insiders. Comparatively, 14.2% of Zura Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Zura Bio's return on equity of -42.84% beat Cognition Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Cognition TherapeuticsN/A -194.42% -115.14%
Zura Bio N/A -42.84%-35.22%

Cognition Therapeutics has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Comparatively, Zura Bio has a beta of -0.1, indicating that its share price is 110% less volatile than the S&P 500.

In the previous week, Cognition Therapeutics had 4 more articles in the media than Zura Bio. MarketBeat recorded 5 mentions for Cognition Therapeutics and 1 mentions for Zura Bio. Zura Bio's average media sentiment score of 1.79 beat Cognition Therapeutics' score of 0.43 indicating that Zura Bio is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cognition Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Zura Bio
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Zura Bio beats Cognition Therapeutics on 8 of the 13 factors compared between the two stocks.

Get Cognition Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CGTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CGTX vs. The Competition

MetricCognition TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$19.36M$2.88B$5.54B$8.87B
Dividend YieldN/A2.64%5.39%4.10%
P/E Ratio-0.4521.3126.1919.90
Price / SalesN/A278.47414.04113.66
Price / CashN/A41.4736.1356.90
Price / Book1.087.518.025.38
Net Income-$33.97M-$55.05M$3.15B$248.50M
7 Day Performance3.30%2.07%1.48%2.06%
1 Month Performance8.16%4.84%3.67%4.86%
1 Year Performance-81.06%5.37%34.68%20.24%

Cognition Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CGTX
Cognition Therapeutics
2.9548 of 5 stars
$0.34
+7.3%
$2.83
+745.3%
-81.6%$19.36MN/A-0.4520Gap Up
ZURA
Zura Bio
3.3019 of 5 stars
$1.05
flat
$14.33
+1,265.1%
-67.3%$71.79MN/A-1.503Positive News
ONCY
Oncolytics Biotech
1.8251 of 5 stars
$0.77
+3.0%
$4.33
+460.6%
-20.5%$70.77MN/A-2.6730
QNCX
Quince Therapeutics
3.5268 of 5 stars
$1.65
+6.5%
$8.00
+384.8%
+116.9%$70.48MN/A-1.1960
PYXS
Pyxis Oncology
1.6157 of 5 stars
$1.10
flat
$9.00
+718.2%
-59.2%$68.14M$16.15M-0.6960Positive News
BMEA
Biomea Fusion
2.9613 of 5 stars
$1.80
-0.6%
$21.40
+1,088.9%
-62.8%$68.01MN/A-0.5150Positive News
INCR
InterCure
0.905 of 5 stars
$1.47
-1.3%
N/A-27.8%$67.90M$66.28M0.00350High Trading Volume
ABOS
Acumen Pharmaceuticals
1.9432 of 5 stars
$1.16
+3.6%
$6.33
+446.0%
-50.2%$67.84MN/A-0.6020News Coverage
Positive News
IMUX
Immunic
2.6203 of 5 stars
$0.70
-0.4%
$11.60
+1,563.1%
-38.0%$67.07MN/A-0.5770
IKNA
Ikena Oncology
3.1764 of 5 stars
$1.34
-1.5%
$3.00
+123.9%
-19.6%$65.63M$9.16M-1.5670Positive News
MNOV
MediciNova
1.843 of 5 stars
$1.31
-1.5%
$7.00
+434.4%
-9.3%$65.23M$1M-5.7010Gap Down

Related Companies and Tools


This page (NASDAQ:CGTX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners